Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 401 | $417.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 402 | $412.14M | Healthcare | Biotechnology | — | Nasdaq |
| 403 | $411.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 404 | $410.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 405 | $407.52M | Healthcare | Healthcare Providers | United States | NYSE |
| 406 | $405.55M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 407 | $404.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 408 | $404.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 409 | $400.81M | Healthcare | Medical Devices | United States | Nasdaq |
| 410 | $400.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 411 | $396.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 412 | $392.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 413 | $388.44M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 414 | $387.15M | Healthcare | Medical Devices | United States | Nasdaq |
| 415 | $385.49M | Healthcare | Biotechnology | United States | Nasdaq |
| 416 | $383.22M | Healthcare | Biotechnology | United States | Nasdaq |
| 417 | $380.37M | Healthcare | Biotechnology | United States | Nasdaq |
| 418 | $373.70M | Healthcare | Medical Devices | United States | NYSE |
| 419 | $366.82M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 420 | $356.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 421 | $356.01M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 422 | $354.02M | Healthcare | Medical Devices | United States | Nasdaq |
| 423 | $351.74M | Healthcare | Pharmaceuticals | United States | NYSE |
| 424 | $349.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 425 | $349.28M | Healthcare | Biotechnology | United States | Nasdaq |
| 426 | $348.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 427 | $346.32M | Healthcare | Medical Devices | United States | Nasdaq |
| 428 | $344.68M | Healthcare | Biotechnology | United States | Nasdaq |
| 429 | $339.37M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 430 | $339.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 431 | $335.99M | Healthcare | Medical Devices | United States | Nasdaq |
| 432 | $329.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 433 | $329.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 434 | $326.81M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 435 | $322.50M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 436 | $320.97M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 437 | $312.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 438 | $312.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 439 | $305.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 440 | $304.49M | Healthcare | Pharmaceuticals | United States | NYSE |
| 441 | $302.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 442 | $302.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 443 | $298.93M | Healthcare | Biotechnology | United States | Nasdaq |
| 444 | $294.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 445 | $293.96M | Healthcare | Medical Devices | United States | Nasdaq |
| 446 | $292.52M | Healthcare | Biotechnology | United States | Nasdaq |
| 447 | $291.35M | Healthcare | Medical Devices | United States | Nasdaq |
| 448 | $290.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 449 | $286.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 450 | $286.05M | Healthcare | Biotechnology | United States | Nasdaq |
| 451 | $285.58M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 452 | $285.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 453 | $285.38M | Healthcare | Pharmaceuticals | United States | NYSE |
| 454 | $285.36M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 455 | $285.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 456 | $283.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 457 | $281.74M | Healthcare | Biotechnology | United States | Nasdaq |
| 458 | $280.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 459 | $276.76M | Healthcare | Medical Devices | United States | Nasdaq |
| 460 | $272.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 461 | $272.43M | Healthcare | Medical Devices | United States | Nasdaq |
| 462 | $270.31M | Healthcare | Medical Devices | United States | Nasdaq |
| 463 | $265.80M | Healthcare | Biotechnology | United States | Nasdaq |
| 464 | $261.41M | Healthcare | Biotechnology | United States | Nasdaq |
| 465 | $259.74M | Healthcare | Medical Devices | United States | NYSE |
| 466 | $258.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 467 | $257.63M | Healthcare | Biotechnology | United States | Nasdaq |
| 468 | $248.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 469 | $247.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 470 | $246.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 471 | $245.57M | Healthcare | Biotechnology | United States | NYSE |
| 472 | $242.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 473 | $241.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 474 | $241.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 475 | $238.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 476 | $238.22M | Healthcare | Health Services | United States | NYSE |
| 477 | $237.16M | Healthcare | Medical Devices | United States | Nasdaq |
| 478 | $235.67M | Healthcare | Medical Devices | United States | NYSE |
| 479 | $231.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 480 | $229.42M | Healthcare | Medical Devices | United States | Nasdaq |
| 481 | $225.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 482 | $223.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 483 | $218.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 484 | $217.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 485 | $216.74M | Healthcare | Biotechnology | United States | NYSE |
| 486 | $214.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 487 | $214.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 488 | $214.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 489 | $210.43M | Healthcare | Medical Devices | United States | Nasdaq |
| 490 | $209.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 491 | $205.43M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 492 | $203.50M | Healthcare | Biotechnology | United States | Nasdaq |
| 493 | $199.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 494 | $197.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 495 | $194.68M | Healthcare | Medical Devices | United States | Nasdaq |
| 496 | $194.24M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 497 | $192.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 498 | $192.06M | Healthcare | Biotechnology | United States | Nasdaq |
| 499 | $191.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 500 | $189.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 890 companies. Market capitalization in USD.